← SynDRA
SQUALAMINE
SynDRA canonical compound SYN0016690 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Mechanism of action | antiviral |
|---|
All known targets
Mechanisms of action (all sources)
- SLC9A3 INHIBITOR
- Sodium/hydrogen exchanger 3 inhibitor
- antiviral
- FGF2 MODULATOR
- PDGFA INHIBITOR
Drug classes
- Angiogenesis Inhibitors
- Anti-Bacterial Agents
- Anticarcinogenic Agents
Cross-references
Synonyms
- Escualamina
- Squalamine [INN]
- UNII-F8PO54Z4V7
- F8PO54Z4V7
- CHEBI:80765
- 3beta-N-1-(N-(3-(4-Aminobutyl))-1,3-diaminopropane)-7alpha,24-dihydroxy-5alpha-cholestane 24-sulfate
- (3beta,5alpha,7alpha,24R)-3-((3-(4-(Aminobutyl)amino)propyl)amio)cholestane-7,24-diol 24-(hydrogen sulfate)
- 3-((3-(4-(Aminobutyl)amino)propyl)amio)cholestane-7,24-diol 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-
- Cholestane-7,24-diol, 3-((3-(4-(aminobutyl)amino)propyl)amio)-, 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-
- escualamina
- squalaminum
- RefChem:185141
- DTXCID90820895
- MSI-1256
- C34H65N3O5S
- SQUALAMINE [MI]
- SQUALAMINE [WHO-DD]
- SCHEMBL12836
- orb1708468
- GTPL10861
- 7alpha-Hydroxy, 3beta-spermidine
- UIRKNQLZZXALBI-MSVGPLKSSA-N
- MSI-1256F (squalamine lactate)
- LMST05050024
- MFCD15146903
- AKOS030526099
- DA-67737
- FS162105
- HY-16468
- MS-30835
- NS00071902
- F85142
- T12995
- Squalamine Lactate
- 4WE915J1KX
- Squalamine lactate [USAN]
- SQUALAMINE LACTATE [WHO-DD]
- RefChem:932120
Look up SQUALAMINE in the interactive SynDRA portal →